Skip to content

Co-treatment with Palbociclib and CDK2-specific Inhibitors to Suppress Tumor Adaptation to CDK2 Inhibitors

Characterization of the real-time response of cancer cells to small-molecule CDK2 inhibitors

Published: 16th February 2022
Co-treatment with Palbociclib and CDK2-specific Inhibitors to Suppress Tumor Adaptation to CDK2 Inhibitors
Source: krishnacreations, https://stock.adobe.com/uk/71624486, stock.adobe.com
Seeking
  • Licensing